{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:34Z","timestamp":1791412054000,"version":"4.3.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00296-016-3632-y","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T02:02:23Z","timestamp":1482544943000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Predrag","family":"Ostojic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Stojanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"3632_CR1","doi-asserted-by":"crossref","first-page":"v54","DOI":"10.1093\/rheumatology\/ken307","volume":"47","author":"CP Denton","year":"2008","unstructured":"Denton CP (2008) Renal manifestations of systemic sclerosis-clinical features and outcome assessments. Rheumatology 47:v54\u2013v56","journal-title":"Rheumatology"},{"key":"3632_CR2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","volume":"100","author":"H Penn","year":"2007","unstructured":"Penn H, Howie AJ, Kingdon EJ et al (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. Q J Med 100:485\u2013494","journal-title":"Q J Med"},{"key":"3632_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","volume":"67","author":"L Teixeira","year":"2008","unstructured":"Teixeira L, Mouthon L, Mahr A et al (2008) Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis 67:110\u2013116","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3632_CR4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","volume":"31","author":"DC Trostle","year":"1988","unstructured":"Trostle DC, Bedetti CD, Steen VD et al (1988) Renal vascular histology and morphometry in systemic sclerosis. A case\/control autopsy study. Arthritis Rheum 31(3):393\u2013400","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3632_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","volume":"42","author":"EJ Kingdon","year":"2003","unstructured":"Kingdon EJ, Knight CJ, Dustan K et al (2003) Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment. Rheumatology 42(1):26\u201333","journal-title":"Rheumatology"},{"key":"3632_CR6","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1\u2013S266","journal-title":"Am J Kidney Dis"},{"key":"3632_CR7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66:940\u2013944","journal-title":"Ann Rheum Dis"},{"key":"3632_CR8","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1600-6143.2004.00605.x","volume":"4","author":"EM Gibney","year":"2004","unstructured":"Gibney EM, Parikh CR, Jani A et al (2004) Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity. Am J Transplant 4:2027\u20132031","journal-title":"Am J Transplant"},{"key":"3632_CR9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","volume":"41","author":"VD Steen","year":"1998","unstructured":"Steen VD, Medsger TA (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613\u20131619","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3632_CR10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-010-1389-3","volume":"29","author":"RH Mohamed","year":"2010","unstructured":"Mohamed RH, Zayed HS, Amin A (2010) Renal disease in systemic sclerosis with normal serum creatinine. Clin Rheumatol 29(7):729\u2013737","journal-title":"Clin Rheumatol"},{"issue":"4","key":"3632_CR11","first-page":"649","volume":"32","author":"VD Steen","year":"2005","unstructured":"Steen VD, Syzd HS, Johnson JP et al (2005) Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32(4):649\u2013655","journal-title":"J Rheumatol"},{"issue":"4","key":"3632_CR12","first-page":"281","volume":"31","author":"P Ostojic","year":"2004","unstructured":"Ostojic P, Damjanov N, Pavlov-Dolijanovic S et al (2004) Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease. Clin Hemorheol Microcirc 31(4):281\u2013285","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1","key":"3632_CR13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.2007.072686","volume":"67","author":"SI Nihtyanova","year":"2008","unstructured":"Nihtyanova SI, Brough GM, Black CM et al (2008) Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 67(1):120\u2013123","journal-title":"Ann Rheum Dis"},{"key":"3632_CR14","first-page":"3","volume":"1","author":"MR Weir","year":"2000","unstructured":"Weir MR, Froch L (2000) Weighing the renal effects of NSAIDs and COX2-inhibitors. Clin Dilemmas 1:3\u201312","journal-title":"Clin Dilemmas"},{"key":"3632_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1987.164","volume":"32","author":"C Patrono","year":"1987","unstructured":"Patrono C, Dunn MJ (1987) The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 32:1\u201312","journal-title":"Kidney Int"},{"key":"3632_CR16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0002-8703(99)70101-8","volume":"138","author":"BA Bart","year":"1999","unstructured":"Bart BA, Goldsmith SR (1999) Aggravated renal dysfunction and the acute management of advanced chronic heart failure. Am Heart J 138:200\u2013202","journal-title":"Am Heart J"},{"key":"3632_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-8703(99)70113-4","volume":"138","author":"MS Weinfeld","year":"1999","unstructured":"Weinfeld MS, Chertow GM, Stevenson LW (1999) Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138:285\u2013290","journal-title":"Am Heart J"},{"key":"3632_CR18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-8703(99)70009-8","volume":"138","author":"EL Knight","year":"1999","unstructured":"Knight EL, Glynn RJ, McIntyre KM et al (1999) Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the study of left ventricular dysfunction (SOLVD). Am Heart J 138:849\u2013855","journal-title":"Am Heart J"},{"key":"3632_CR19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1681\/ASN.V16845","volume":"1","author":"DE Hricik","year":"1990","unstructured":"Hricik DE, Dunn MJ (1990) Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1:845\u2013858","journal-title":"J Am Soc Nephrol"},{"key":"3632_CR20","first-page":"67","volume":"17","author":"SC Textor","year":"1997","unstructured":"Textor SC (1997) Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol 17:67\u201376","journal-title":"Semin Nephrol"},{"key":"3632_CR21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2165\/00002018-199615030-00005","volume":"15","author":"G Navis","year":"1996","unstructured":"Navis G, Faber HJ, de Zeeuw D et al (1996) ACE inhibitors and the kidney: a risk-benefit assessment. Drug Saf 15:200\u2013211","journal-title":"Drug Saf"},{"key":"3632_CR22","first-page":"170","volume":"42","author":"AK Mandal","year":"1994","unstructured":"Mandal AK, Markert RJ, Saklayen MG et al (1994) Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure. Clin Nephrol 42:170\u2013174","journal-title":"Clin Nephrol"},{"issue":"2","key":"3632_CR23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.amjms.2016.04.017","volume":"352","author":"P Suebmee","year":"2016","unstructured":"Suebmee P, Foocharoen C, Mahakkanukrauh A et al (2016) Correlation of glomerular filtration rate between renal scan and estimation equation for patients with scleroderma. Am J Med Sci 352(2):166\u2013171","journal-title":"Am J Med Sci"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3632-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T21:16:37Z","timestamp":1658265397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3632-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3632-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,22]]}}}